These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3727904)

  • 1. Animal model of depression: imipramine, bromocriptine and lisuride alleviate motor depression.
    Golda V; Petr R; Rozsíval V; Suba P
    Act Nerv Super (Praha); 1986 Mar; 28(1):26-7. PubMed ID: 3727904
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactivity to the electric shocks and motor depression as a consequence of inescapable shocking: the effect of acute lisuride treatment.
    Golda V; Petr R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(4):377-92. PubMed ID: 6599815
    [No Abstract]   [Full Text] [Related]  

  • 3. Animal model of depression: retention of motor depression not predictable from the threshold of reaction to the inescapable shock.
    Golda V; Petr R
    Act Nerv Super (Praha); 1987 Jun; 29(2):113-4. PubMed ID: 3661094
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal model of depression: drug induced changes independent of changes in exploratory activity.
    Golda V; Petr R
    Act Nerv Super (Praha); 1987 Jun; 29(2):114-5. PubMed ID: 3661095
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex and strain dependence in the effect of lisuride and tranylcypromine in motor depression and its relationship to the sex and strain dependence pattern of parameters related to stress mechanism.
    Golda V; Petr R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(2):279-97. PubMed ID: 3481877
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal model of depression: effect of nicotergoline and metergoline.
    Golda V; Petr R
    Act Nerv Super (Praha); 1987 Jun; 29(2):115-7. PubMed ID: 3661096
    [No Abstract]   [Full Text] [Related]  

  • 7. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
    LeWitt PA; Burns RS; Calne DB
    Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
    Horowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):147-51. PubMed ID: 36572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine and lisuride in dystonias.
    Obeso JA; Luquin MR
    Neurology; 1984 Jan; 34(1):135-6. PubMed ID: 6537848
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of acute lisuride treatment on behavior in elevated plus-maze (animal model of anxiety) and on the exploratory activity in holeboard.
    Golda V; Petr R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1988; 31(1):45-60. PubMed ID: 3206175
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral lisuride in Parkinson's disease].
    Obeso JA; Luquin MR; Martínez Lage JM
    Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
    [No Abstract]   [Full Text] [Related]  

  • 13. Lisuride in parkinsonism.
    Gopinathan G; Teräväinen H; Dambrosia JM; Ward CD; Sanes JN; Stuart WK; Evarts EV; Calne DB
    Neurology; 1981 Apr; 31(4):371-6. PubMed ID: 7194429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine--lisuride cross tolerance.
    Giovannini P; Scigliano G; Grassi MP; Carella F; Parati E; Caraceni T
    Ital J Neurol Sci; 1983 Apr; 4(1):129-30. PubMed ID: 6862842
    [No Abstract]   [Full Text] [Related]  

  • 15. Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine.
    Keller HH; Da Prada M
    Life Sci; 1979 Mar; 24(13):1211-21. PubMed ID: 36540
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial effects of lisuride in Meige disease.
    Micheli F; Fernández Pardal MM; Leiguarda RC
    Neurology; 1982 Apr; 32(4):432-4. PubMed ID: 7199669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
    Al-Sereiti MR; Turner P
    Br J Clin Pharmacol; 1989 Feb; 27(2):159-63. PubMed ID: 2713211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects in animal models of depression of lisuride alone and upon coadministration with antidepressants].
    Nakamura K; Ikoma Y; Kimura K; Nakada Y; Kobayashi S; Yamaguchi M; Nakagawa H
    Nihon Yakurigaku Zasshi; 1989 Jul; 94(1):81-9. PubMed ID: 2792964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.